- Home
- PCRX vs SSYS Comparison
PCRX vs SSYS Comparison
Compare PCRX & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- SSYS
- Stock Information
- Founded
- PCRX 2006
- SSYS 1989
- Country
- PCRX United States
- SSYS United States
- Employees
- PCRX N/A
- SSYS N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- PCRX Health Care
- SSYS Technology
- Exchange
- PCRX Nasdaq
- SSYS Nasdaq
- Market Cap
- PCRX 604.7M
- SSYS 634.6M
- IPO Year
- PCRX 2011
- SSYS 1994
- Fundamental
- Price
- PCRX $22.06
- SSYS $9.02
- Analyst Decision
- PCRX Buy
- SSYS Strong Buy
- Analyst Count
- PCRX 10
- SSYS 4
- Target Price
- PCRX $27.60
- SSYS $11.50
- AVG Volume (30 Days)
- PCRX 775.7K
- SSYS 478.7K
- Earning Date
- PCRX 02-27-2025
- SSYS 03-06-2025
- Dividend Yield
- PCRX N/A
- SSYS N/A
- EPS Growth
- PCRX N/A
- SSYS N/A
- EPS
- PCRX N/A
- SSYS N/A
- Revenue
- PCRX $694,957,000.00
- SSYS $578,436,000.00
- Revenue This Year
- PCRX $4.83
- SSYS N/A
- Revenue Next Year
- PCRX $2.16
- SSYS $3.22
- P/E Ratio
- PCRX N/A
- SSYS N/A
- Revenue Growth
- PCRX 4.40
- SSYS N/A
- 52 Week Low
- PCRX $11.16
- SSYS $6.05
- 52 Week High
- PCRX $34.01
- SSYS $14.22
- Technical
- Relative Strength Index (RSI)
- PCRX 69.57
- SSYS 47.79
- Support Level
- PCRX $18.18
- SSYS $8.36
- Resistance Level
- PCRX $22.36
- SSYS $9.10
- Average True Range (ATR)
- PCRX 1.09
- SSYS 0.45
- MACD
- PCRX 0.26
- SSYS -0.06
- Stochastic Oscillator
- PCRX 91.10
- SSYS 48.18
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.